DURAGESIC-12

LOE Approaching

fentanyl

NDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Aug 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

agonist. Fentanyl interacts predominately with the opioid mu-receptor. These mu-binding sites are distributed in the human brain, spinal cord, and other tissues.

Clinical Trials (5)

NCT06953453Phase 1Recruiting

A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors

Started Sep 2025
100 enrolled
Cancer
NCT05531422Phase 2Completed

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

Started Oct 2021
60 enrolled
Breakthrough Cancer Pain
NCT04713189Phase 1/2Unknown

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain

Started Mar 2021
96 enrolled
Breakthrough Cancer Pain
NCT04136548Phase 1/2Completed

Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl

Started Jun 2019
41 enrolled
Healthy
NCT03869346N/AUnknown

Impact of CYP3A4*1G Polymorphism on Non-analgesic Effects of Fentanyl in Chinese Han Patients

Started Mar 2019
200 enrolled
Fentanyl